Comparative efficacy of biologics and small molecule drugs in treating pediatric atopic dermatitis in patients aged 2–18 years: A 12–16 week network meta‐analysis of randomized controlled trials

Documenti analoghi

• Ocular surface disease in pediatric patients with moderate‐to‐severe atopic dermatitis
  di: Lisa P. van der Rijst, et al.
  Pubblicazione: (2025)
• Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity
  di: Paola Zangari, et al.
  Pubblicazione: (2024)
• Ruxolitinib cream improves outcomes in atopic dermatitis: An updated systematic review and meta‐analysis
  di: Laura Ghanem, et al.
  Pubblicazione: (2026)
• Emulsion containing a chitosan derivative in children with mild atopic dermatitis: A randomized controlled trial
  di: Nagatoshi Sagara, et al.
  Pubblicazione: (2025)
• Skin and gut microbiome in atopic dermatitis: Mechanisms and therapeutic opportunities
  di: Binbin Hou, et al.
  Pubblicazione: (2025)